Concepedia

Publication | Open Access

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort

DOIFull Paper Access

35

Citations

35

References

2016

Year

Chao‐Hsiun Tang, Chia‐Chen Wang, Tso‐Hsiao Chen, Chuang‐Ye Hong, Yuh‐Mou Sue
Journal of the American Heart Association

Abstract

This study demonstrates that the 3 β-blockers were associated with improved survival in long-term hemodialysis patients with heart failure.

References

YearCitations

Page 1